These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 778618)

  • 21. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
    Moskowitz RM; Cohn JN
    Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension.
    Falch DK; Odegaard AE; Norman N
    Scand J Clin Lab Invest; 1978 Apr; 38(2):143-6. PubMed ID: 653302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A difficult diagnosis?].
    Hassler L
    Lakartidningen; 1972 Nov; 69(49):5737 passim. PubMed ID: 4651839
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydrallazine in hypertension: is there a safe dose?
    Bing RF; Russell GI; Thurston H; Swales JD
    Br Med J; 1980 Aug; 281(6236):353-4. PubMed ID: 6968614
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers.
    Peterson LL
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):379-84. PubMed ID: 6231317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinuclear antibodies following hydralazine toxicity.
    Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
    N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of arterial hypertension with the combination of hydralazine and propranolol].
    Sabbaga E; Chocair PR; Ianhez LE; Massola VC
    Rev Paul Med; 1974 Mar; 83(3):97-100. PubMed ID: 4445689
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatemtn of arterial hypertension with the combination of hydralazine and propranolol].
    Sabbaga E; Chocair PR; Ianhez LE; Massola VC
    Rev Paul Med; 1974 Mar; 83(3):97-100. PubMed ID: 4445688
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypocomplementemia in hydralazine-associated systemic lupus erythematosus.
    Weinstein J
    Am J Med; 1978 Sep; 65(3):553-6. PubMed ID: 717423
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral haemodynamics in essential hypertension.
    Sivertsson R
    Acta Med Scand Suppl; 1977; 606():43-7. PubMed ID: 19929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
    Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
    Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Foad B; Loggie JH; Hess EV
    Clin Pharmacol Ther; 1981 Apr; 29(4):447-56. PubMed ID: 6970646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hydralazine-induced lupus presenting as systemic lupus erythematosus.
    Rubin RL; Haluptzok RF; Davila LM
    Lupus; 2020 Apr; 29(5):509-513. PubMed ID: 32041503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of hypertension and systemic lupus erythematosus.
    Vogl A
    Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():157-8. PubMed ID: 5293512
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydralazine-induced lupus syndrome.
    French WJ
    Ala J Med Sci; 1984 Oct; 21(4):427-30. PubMed ID: 6507805
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
    Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
    Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Procainamide- and hydralazine-induced antinuclear antibodies in Japanese].
    Nishikai M; Sugimoto M; Sato A; Honda M; Naito M; Nagoshi H
    Nihon Naika Gakkai Zasshi; 1987 May; 76(5):686-8. PubMed ID: 3509914
    [No Abstract]   [Full Text] [Related]  

  • 40. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.